相关实验视频

Updated: May 5, 2026

The MultiBac Protein Complex Production Platform at the EMBL
13:51

The MultiBac Protein Complex Production Platform at the EMBL

Published on: July 11, 2013

16.6K

在 Bacillus subtilis 中,通过对遗传元素的组合优化,高效地生产复合糖酸酶

Tian Gan1, Fan Zhang1, Ming Zhuo1

  • 1State Key Laboratory of Green Chemical Synthesis and Conversion, College of Biotechnology and Bioengineering, Zhejiang University of Technology, Hangzhou, 310014, China; Institute of Fermentation Engineering, Zhejiang University of Technology, Hangzhou, 310014, China.

International journal of biological macromolecules
|October 5, 2025
PubMed
概括

使用促进体工程和RBS查优化Bacillus subtilis中糖酸酶 (SPase) 表达,显著提高了酶的产生. 这导致了一种高效的生物工艺,用于生产2-O-α-d-glucopyranosyl glycerol (2-αGG).

关键词:
2-O-α-d-glucopyranosyl糖二氧化二氧化-α-d-glucopyranosyl糖二氧化二氧化二氧化二氧化这种细菌是 Bacillus subtilis.发起人工程 发起人工程瑞银的工程工程是RBS的工程.糖酸酸酶是一种糖糖酸酸酶.

更多相关视频

Generic Protocol for Optimization of Heterologous Protein Production Using Automated Microbioreactor Technology06:24

Generic Protocol for Optimization of Heterologous Protein Production Using Automated Microbioreactor Technology

Published on: December 15, 2017

10.6K
Production of Recombinant PRMT Proteins using the Baculovirus Expression Vector System08:57

Production of Recombinant PRMT Proteins using the Baculovirus Expression Vector System

Published on: July 17, 2021

8.2K

相关概念视频

Bioreactor Controls-III01:22

Bioreactor Controls-III

Strain improvement is a foundational strategy in industrial microbiology aimed at maximizing microbial productivity, particularly because natural isolates typically yield commercially valuable products in very low concentrations. Although optimizing the culture medium and environmental conditions can improve yields, these adjustments are inherently limited by the organism’s genetic potential. As a result, the focus shifts toward genetic modifications to enhance biosynthetic capacity. The...
67
Upstream Processing01:27

Upstream Processing

Upstream processing represents a critical phase in biomanufacturing, wherein biological systems such as microorganisms, mammalian cells, or insect cells are cultivated to produce therapeutic proteins, vaccines, enzymes, or other biologically derived products. This phase encompasses all steps from the selection and genetic manipulation of the production organism to the cultivation of cells in bioreactors under tightly controlled environmental conditions.Host Selection and Genetic OptimizationThe...
97
Production of Pharmaceuticals01:30

Production of Pharmaceuticals

Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under...
94
Production of Biopesticides01:18

Production of Biopesticides

Biopesticides offer a sustainable alternative to chemical pesticides, utilizing microbial agents to control agricultural pests. Bacillus thuringiensis (Bt) is a widely employed bacterium known for its potent insecticidal activity. Bt biopesticides are favored for their specificity to insect pests, minimal environmental impact, and natural degradability.Mechanism of Bt Toxin Action Bt produces insecticidal crystal (Cry) proteins during its sporulation phase. These proteins form parasporal...
108